The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Failures in Clinical Treatment of Staphylococcus aureus Infection with Daptomycin Are Associated with Alterations in Surface Charge, Membrane Phospholipid Asymmetry, and Drug Binding
Open accessAbstract
Increasingly frequent reports have described the in vivo loss of daptomycin susceptibility in association with clinical treatment failures. The mechanism(s) of daptomycin resistance is not well understood. We studied an isogenic set of Staphylococcus aureus isolates from the bloodstream of a daptomycin-treated patient with recalcitrant endocarditis in which serial strains exhibited decreasing susceptibility to daptomycin. Since daptomycin is a membrane-targeting lipopeptide, we compared a number of membrane parameters in the initial blood isolate (parental) with those in subsequent daptomycin-resistant strains obtained during treatment. In comparison to the parental strain, resistant isolates demonstrated (i) enhanced membrane fluidity, (ii) increased translocation of the positively charged phospholipid lysyl-phosphotidylglycerol to the outer membrane leaflet, (iii) increased net positive surface charge ( P < 0.05 versus the parental strain), (iv) reduced susceptibility to daptomycin-induced depolarization, permeabilization, and autolysis ( P < 0.05 versus the parental strain), (v) significantly lower surface binding of daptomycin ( P < 0.05 versus the parental strain), and (vi) increased cross-resistance to the cationic antimicrobial host defense peptides human neutrophil peptide 1 (hNP-1) and thrombin-induced platelet microbicidal protein 1 (tPMP-1). These data link distinct changes in membrane structure and function with in vivo development of daptomycin resistance in S. aureus . Moreover, the cross-resistance to hNP-1 and tPMP-1 may also impact the capacity of these daptomycin-resistant organisms to be cleared from sites of infection, particularly endovascular foci.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
Peschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G., & Götz, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8405 · Cited by 994
Peschel, A., Jack, R. W., Otto, M., Collins, L. V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, W. F., Jung, G., Tarkowski, A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1067 · Cited by 786
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.
Lehrer, R. I., Barton, A., Daher, K. A., Harwig, S. S., Ganz, T., & Selsted, M. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114198 · Cited by 715
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Silverman, J. A., Perlmutter, N. G., & Shapiro, H. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2538-2544.2003 · Cited by 656
Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus
Friedman, L., Alder, J. D., & Silverman, J. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00039-06 · Cited by 454
Cui, L., Tominaga, E., Neoh, H.-M., & Hiramatsu, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1079-1082.2006 · Cited by 427
Charles, P. G. P., Ward, P. B., Johnson, P. D. R., Howden, B. P., & Grayson, M. L. (2004) · Clinical Infectious Diseases · doi:10.1086/381093 · Cited by 384
Structural Transitions as Determinants of the Action of the Calcium-Dependent Antibiotic Daptomycin
Jung, D., Rozek, A., Okon, M., & Hancock, R. E. W. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.020 · Cited by 297
Staphylococcus aureus resistant to vancomycin--United States, 2002.
(2002) · PubMed · Cited by 289
Sakoulas, G., Alder, J., Thauvin-Eliopoulos, C., Moellering, R. C., & Eliopoulos, G. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1581-1585.2006 · Cited by 262
Self-citationDaptomycin‐Resistant, Methicillin‐Resistant Staphylococcus aureus Bacteremia
Mangili, A., Bica, I., Snydman, D. R., & Hamer, D. H. (2005) · Clinical Infectious Diseases · doi:10.1086/428616 · Cited by 256
Binding of peptides with basic residues to membranes containing acidic phospholipids
Kim, J., Mosior, M., Chung, L. A., Wu, H., & McLaughlin, S. (1991) · Biophysical Journal · doi:10.1016/s0006-3495(91)82037-9 · Cited by 243
Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus
Hayden, M. K., Rezai, K., Hayes, R. A., Lolans, K., Quinn, J. P., & Weinstein, R. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5285-5287.2005 · Cited by 241
Lehrer, R. I., Barton, A., & Ganz, T. (1988) · Journal of Immunological Methods · doi:10.1016/0022-1759(88)90414-0 · Cited by 211
Marty, F. M., Yeh, W. W., Wennersten, C. B., Venkataraman, L., Albano, E., Alyea, E. P., Gold, H. S., Baden, L. R., & Pillai, S. K. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.595-597.2006 · Cited by 199
Yeaman, M. R., Bayer, A. S., Koo, S. P., Foss, W., & Sullam, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci562 · Cited by 189
Self-citationEssodaïgui, M., Broxterman, H. J., & Garnier-Suillerot, A. (1998) · Biochemistry · doi:10.1021/bi9718043 · Cited by 189
Klein, W., Weber, M. H. W., & Marahiel, M. A. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.17.5341-5349.1999 · Cited by 188
Treatment Failure Resulting from Resistance of Staphylococcus aureus to Daptomycin
Skiest, D. J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.655-656.2006 · Cited by 167
Hartmann, W., & Galla, H. (1978) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(78)90241-9 · Cited by 158
Bayer, A. S., Prasad, R., Chandra, J., Koul, A., Smriti, M., Varma, A., Skurray, R. A., Firth, N., Brown, M. H., Koo, S.-P., et al. (2000) · Infection and Immunity · doi:10.1128/iai.68.6.3548-3553.2000 · Cited by 150
Moore, M. R., Perdreau‐Remington, F., & Chambers, H. F. “. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1262-1266.2003 · Cited by 149
Purification and in vitro activities of rabbit platelet microbicidal proteins
Yeaman, M. R., Tang, Y., Shen, A. J., Bayer, A. S., & Selsted, M. E. (1997) · Infection and Immunity · doi:10.1128/iai.65.3.1023-1031.1997 · Cited by 140
Self-citationMohedano, M. L., Overweg, K., de la Fuente, A., Reuter, M., Altabe, S., Mulholland, F., de Mendoza, D., López, P., & Wells, J. M. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2357-2367.2005 · Cited by 135
Sakoulas, G., Eliopoulos, G. M., Alder, J. D., & Eliopoulos, C. T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1714-1718.2003 · Cited by 133
Self-citationThe conducting form of gramicidin A is a right-handed double-stranded double helix
Burkhart, B. M., Li, N., Langs, D. A., Pangborn, W. A., & Duax, W. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.12950 · Cited by 123
Xiong, Y. Q., Mukhopadhyay, K., Yeaman, M. R., Adler‐Moore, J., & Bayer, A. S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3114-3121.2005 · Cited by 118
Self-citationXiong, Y.-Q., Yeaman, M. R., & Bayer, A. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1111 · Cited by 107
Self-citationMukhopadhyay, K., Whitmire, W. M., Xiong, Y. Q., Molden, J., Jones, T., Peschel, A., Neumann‐Staubitz, P., Adler‐Moore, J., McNamara, P. J., Proctor, R. A., et al. (2007) · Microbiology · doi:10.1099/mic.0.2006/003111-0 · Cited by 93
Self-citationSynthetic Peptides That Exert Antimicrobial Activities in Whole Blood and Blood-Derived Matrices
Yeaman, M. R., Gank, K. D., Bayer, A. S., & Brass, E. P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3883-3891.2002 · Cited by 90
Self-citationMechanisms of daptomycin resistance in Staphylococcus aureus
Kaatz, G. W., Lundstrom, T. S., & Seo, S. M. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.05.030 · Cited by 85
Gramicidin D conformation, dynamics and membrane ion transport
Burkhart, B. M., Gassman, R. M., Langs, D. A., Pangborn, W. A., Duax, W. L., & Pletnev, V. Z. (1999) · Biopolymers · doi:10.1002/(sici)1097-0282(1999)51:2<129::aid-bip3>3.0.co;2-y · Cited by 84
Pillai, S. K., Gold, H. S., Sakoulas, G., Wennersten, C. B., Moellering, R. C., & Eliopoulos, G. M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00202-07 · Cited by 82
Self-citationKoo, S.-P., Bayer, A. S., Sahl, H., Proctor, R. A., & Yeaman, M. R. (1996) · Infection and Immunity · doi:10.1128/iai.64.3.1070-1074.1996 · Cited by 80
Self-citationPlatelet Microbicidal Protein 1: Structural Themes of a Multifunctional Antimicrobial Peptide
Yount, N. Y., Gank, K. D., Xiong, Y. Q., Bayer, A. S., Pender, T., Welch, W. H., & Yeaman, M. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4395-4404.2004 · Cited by 68
Self-citationDogra, S., Krishnamurthy, S., Gupta, V., Dixit, B. L., Gupta, C. M., Sanglard, D., & Pprasad, R. (1999) · Yeast · doi:10.1002/(sici)1097-0061(19990130)15:2<111::aid-yea350>3.0.co;2-e · Cited by 67
Wootton, M., MacGowan, A. P., & Walsh, T. R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00678-06 · Cited by 67
Xiong, Y.-Q., Bayer, A. S., & Yeaman, M. R. (2002) · The Journal of Infectious Diseases · doi:10.1086/338514 · Cited by 62
Self-citationKupferwasser, L. I., Yeaman, M. R., Shapiro, S., Nast, C. C., & Bayer, A. S. (2002) · Circulation · doi:10.1161/hc0602.103721 · Cited by 61
Self-citationBayer, A. S., McNamara, P. J., Yeaman, M. R., Lucindo, N., Jones, T., Cheung, A. L., Sahl, H., & Proctor, R. A. (2005) · Journal of Bacteriology · doi:10.1128/jb.188.1.211-222.2006 · Cited by 56
Self-citationJorgensen, J. H., Crawford, S. A., Kelly, C. C., & PATTERSON, J. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3760-3763.2003 · Cited by 52
Diversity in Antistaphylococcal Mechanisms among Membrane-Targeting Antimicrobial Peptides
Koo, S.-P., Bayer, A. S., & Yeaman, M. R. (2001) · Infection and Immunity · doi:10.1128/iai.69.8.4916-4922.2001 · Cited by 52
Self-citationHuijbregts, R. P. H., de Kroon, A. I. P. M., & KRUIJFF, B. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18936 · Cited by 46
Long-term oral ciprofloxacin: Experience in the treatment of incurable infective endocarditis
Daikos, G. L., Kathpalia, S. B., Lolans, V. T., et al. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90122-2 · Cited by 41
Koo, S.-P., Bayer, A. S., Kagan, B. L., & Yeaman, M. R. (1999) · Infection and Immunity · doi:10.1128/iai.67.5.2475-2481.1999 · Cited by 31
Self-citationXiong, Y. Q., Bayer, A. S., Elazegui, L., & Yeaman, M. R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00038-06 · Cited by 25
Self-citationDixit, B. L., & Gupta, C. M. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540202.x · Cited by 16
The Effects of Daptomycin on Chemical Composition and Morphology of Staphylococcus aureus
Condrad, R. S. (1998) · Proceedings of the Oklahoma Academy of Science · Cited by 12
Cited by
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
Mechanisms of antibiotic resistance in enterococci
Miller, W. R., Munita, J. M., & Arias, C. A. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.956092 · Cited by 772
Bacterial stress responses as determinants of antimicrobial resistance
Poole, K. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks196 · Cited by 519
Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane
Sabnis, A., Hagart, K. L., Klöckner, A., Becce, M., Evans, L. E., Furniss, R. C. D., Mavridou, D. A., Murphy, R., Stevens, M. M., Davies, J. C., et al. (2021) · eLife · doi:10.7554/elife.65836 · Cited by 389
Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
Arias, C. A., Panesso, D., McGrath, D. M., Qin, X., Mojica, M. F., Miller, C., Diaz, L., Tran, T. T., Rincon, S., Barbu, E. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011138 · Cited by 377
Metadata
- Authors
- Jones, T., Yeaman, M. R., Sakoulas, G., Yang, S.-J., Proctor, R. A., Sahl, H.-G., Schrenzel, J., Xiong, Y. Q., & Bayer, A. S.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2008-01
- Volume
- 52
- Issue
- 1
- Pages
- 269-278
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2148954461
- Cited by
- 318
- References
- 52
- FWCI
- 12.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.